[Skip to Content]
[Skip to Content Landing]
Comment & Response
June 25, 2014

Therapies for Venous Thromboembolism

Author Affiliations
  • 1Yale University School of Medicine, New Haven, Connecticut

Copyright 2014 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.

JAMA. 2014;311(24):2543. doi:10.1001/jama.2014.6114

To the Editor The review by Dr Wells and colleagues1 on the treatment of venous thromboembolism requires some clarifications. Table 1 in the article summarized new oral anticoagulants as treatment options for venous thromboembolism. However, only rivaroxaban is currently approved in both the United States and Europe, dabigatran was recently approved by the US Food and Drug Administration (FDA), and apixaban awaits approval by both the FDA and the European Medicines Agency.

First Page Preview View Large
First page PDF preview
First page PDF preview